Serval Resources Plc
Research Serval Resources Plc (SRVL.L) on Bullrun: market cap GBX 1.02B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSRVL.L
- ExchangeLSE
- CountryUnited Kingdom
- SectorBasic Materials
- IndustryCopper
- CurrencyGBX
- Market capGBX 1.02B
- Financial periodFY2025
- RevenueGBP 0
- Net income-GBP 847.48K
- Free cash flow-GBP 909.63K
Valuation Snapshot
latest market cap is GBX 1.02B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 0 | -GBP 847.48K | -GBP 909.63K | n/a | 0 | GBP 218.62K | n/a | GBP 910.90K |
| FY2024 | GBP 0 | -GBP 3.97M | -GBP 240.43K | n/a | -0.01 | GBP 1.56M | n/a | GBP 1.76M |
| FY2023 | -GBP 104.46K | -GBP 952.60K | -GBP 229.28K | n/a | -0.22 | GBP 1.10M | n/a | GBP 2.51M |
| FY2022 | GBP 8.44K | GBP 336.75K | -GBP 242.14K | n/a | 0.08 | GBP 1.23M | n/a | GBP 3.46M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | GBX 1.02B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About Serval Resources Plc
Serval Resources Plc is a venture capital and private equity firm specializing in special situations, growth capital investments in fledging companies. The firm seeks to invest in listed or unlisted securities through debt or equity. The firm seeks to make investments across sectors including natural resources and technology. The firm also invests in medical psychedelic;
Related stock research
Other Basic Materials stocks
Frequently asked questions
What is Serval Resources Plc's market cap?
Serval Resources Plc's market capitalization is GBX 1.02B.
What does Serval Resources Plc do?
Serval Resources Plc is a venture capital and private equity firm specializing in special situations, growth capital investments in fledging companies. The firm seeks to invest in listed or unlisted securities through debt or equity. The firm seeks to make investments across sectors including natural resources and technology. The firm also invests in medical psychedelic; medicinal cannabis market in companies, projects, or products that are either progressing medicinal or therapeutic cannabis research, or that are in the process of product development.